Legal & General Group
CLLS

Legal & General Group’s Cellectis CLLS Stock Holding History

Legal & General Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-337,201
Closed -$2.74M – 3566
2021
Q4 		$2.74M Buy
337,201
+120,369
+56% +$1.18M ﹤0.01% 1879
2021
Q3 		$2.73M Buy
216,832
+11,040
+5% +$153K ﹤0.01% 1872
2021
Q2 		$3.18M Buy
205,792
+38,011
+23% +$639K ﹤0.01% 1756
2021
Q1 		$3.39M Buy
167,781
+121,560
+263% +$3.01M ﹤0.01% 1760
2020
Q4 		$1.25M Buy
46,221
+1,570
+4% +$35.2K ﹤0.01% 2047
2020
Q3 		$826K Buy
44,651
+14,508
+48% +$257K ﹤0.01% 2082
2020
Q2 		$537K Buy
+30,143
New +$459K ﹤0.01% 2157

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's CLLS Position: Q1 2022 in Review

Legal & General Group sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 337,201 shares — an estimated $2.74M sold.

Legal & General Group first reported a position in CLLS in Q2 2020 and held it in 7 quarters. The position peaked at $3.39M in Q1 2021. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • Legal & General Group reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • Legal & General Group sold 337,201 Cellectis shares in Q1 2022, an estimated $2.74M.
  • Legal & General Group first reported a position in Cellectis in Q2 2020 and held it in 7 quarters.
  • Legal & General Group's Cellectis position peaked at $3.39M in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on Legal & General Group's 13F filing for Q1 2022, filed 16 May 2022.